Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference
| 456837BF9 | 99.50 2.55 2.50% |
About 61% of 456837BF9's investor base is looking to short. The analysis of the overall prospects from investing in ING Groep 6083 suggests that many traders are, at the present time, alarmed. The current market sentiment, together with 456837BF9's historical and current headlines, can help investors time the market. In addition, many technical investors use ING Groep 6083 bond news signals to limit their universe of possible portfolio assets.
456837BF9 |
REDWOOD CITY, Calif., Nov. 19, 2024 -- Codexis, Inc. , a leading provider of enzymatic solutions for efficient and scalable therapeuti
Read at gurufocus.com
 |
ING Groep 6083 Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with 456837BF9 bond to make a market-neutral strategy. Peer analysis of 456837BF9 could also be used in its relative valuation, which is a method of valuing 456837BF9 by comparing valuation metrics with similar companies.
Peers
456837BF9 Related Equities
| DKDRF | Delek Drilling | 5.13 | ||||
| CDXS | Codexis | 1.45 | ||||
| CC | Chemours | 0.05 | ||||
| CF | CF Industries | 0.15 | ||||
| APD | Air Products | 0.35 | ||||
| AVNT | Avient Corp | 1.09 | ||||
| HDSN | Hudson Technologies | 1.29 |
Other Information on Investing in 456837BF9 Bond
456837BF9 financial ratios help investors to determine whether 456837BF9 Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 456837BF9 with respect to the benefits of owning 456837BF9 security.